FDA Creates New Advisory Committee for Evaluation of Genetic Metabolic Disease Treatments

Today, the U.S. Food and Drug Administration announced it is creating a new advisory committee related to potential treatments for genetic metabolic diseases.


Related articles

View all the news and events

MENA Congress for Rare Diseases in Abu Dhabi

From May 16, 2024 to May 19, 2024

This conference is a unique platform that brings all parties involved in rare diseases to one place to obtain the most updated knowledge, increase …